Navigation Links
Advancing the science for patients with rare diseases
Date:2/29/2016

WASHINGTON, Feb. 29, 2016 /PRNewswire-USNewswire/ -- When you have a loved one with a rare disease, the importance of persevering to find new, innovative treatments takes on new meaning. This year on Rare Disease Day, I am excited to celebrate the advances we saw in treatments last year and the hope we have for continued progress in the years ahead.

Rare diseases are those that affect fewer than 200,000 people in the United States, but with more than 7,000 different rare diseases known today, nearly 1 in 10 Americans is living with a rare disease. Eighty percent of rare diseases – including the one impacting my family – are genetic in origin, making the rarity of each disease often unknown and treatment options especially limited. Today, approved treatments are available for just 5 percent of rare diseases.

2015: Banner year for rare diseases
2015: Banner year for rare diseases
Rare diseases by the numbers
Rare diseases by the numbers

But the hope for new treatments and cures has never been greater, with recent advances delivering on the promise of the science for patients. Today, PhRMA released a new fact sheet "Great Strides Against Rare Diseases" highlighting the advancements made for patients in the last year.

2015 was a banner year for advances in rare disease treatments:

  • 47 percent of new drug approvals were for rare diseases (A noteworthy uptick over the average of just over 35 percent in the last five years)
  • 8 first-in-class treatments, representing entirely new ways for treating disease
  • 11 new cancer therapies
  • 5 new medicines for pediatric patients
  • New treatments for cystic fibrosis, difficult-to-treat high cholesterol and several enzyme deficiency disorders

The fact sheet explores 2015 treatment advances in rare diseases, including new therapeutic options for patients with multiple myeloma and cystic fibrosis, as well as new treatments for several rare diseases affecting pediatric patients.

Together as industry, patients and advocates, we must continue to work together to foster research and development for these complex and challenging disease areas and maintain incentives critical to bringing new medicines to patients. The biopharmaceutical industry is committed to finding new treatments and cures for patients with rare diseases, and with 450 medicines in development, patients have more hope than ever before.

Read our Rare Disease Day guest blogs from patients and advocates here: http://catalyst.phrma.org/topic/rare-disease-day

This post originally appeared here: http://catalyst.phrma.org/advancing-the-science-for-patients-with-rare-diseases

Contact: Allyson Funk; 202-835-3460; newsroom@phrma.org

 

Photo - http://photos.prnewswire.com/prnh/20160229/338417 
Photo - http://photos.prnewswire.com/prnh/20160229/338418 
Logo - http://photos.prnewswire.com/prnh/20091027/PHRMALOGO

 


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America (PhRMA)
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. SCPC Praises Bipartisan Collins-Loebsack Letter Advancing Investigation of PBMs Anti-Competitive, Non-Transparent Pricing Practices
2. Foundation Venture Capital Group commits up to $500,000 in start-up advancing technology platform for tissue visualization
3. Oxeia Biopharmaceuticals, Inc. Advancing Development Of OXE-103 For The Treatment Of Concussions
4. New Post Hoc Analyses of Pivotal Trials of Safinamide on Motor Complications and Pain in Advancing Parkinsons Disease
5. Public Responsibility in Medicine and Research (PRIM&R) Hosts 2015 Social, Behavioral, and Educational Research (SBER) Conference and 2015 Advancing Ethical Research (AER) Conference
6. Boehringer Ingelheim Highlights Latest Community and Research Initiatives in Advancing Anticoagulation Care at American Heart Association (AHA) Scientific Sessions 2015
7. Frost & Sullivan Applauds ulrich medical for Advancing Diagnostic Imaging with its Innovative Autoinjector Device
8. ImmunoCellular Therapeutics Issues Letter to Shareholders, Highlighting Progress on Advancing ICT-107 to Phase 3 Registrational Trial
9. Isis Pharmaceuticals Earns $2.15M For Advancing ISIS-SMN Rx in Children with Spinal Muscular Atrophy
10. Kids v Cancer Announces "The Advancing Hope Act" To Reauthorize The Pediatric Priority Review Voucher Program
11. Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/3/2020)... ... 03, 2020 , ... In Partnership with the Smiles for Everyone Foundation ... at its Burleson, TX office on February 8th. , Dental services provided include same-day ... and extractions . For more information, please visit the Monarch Dental website ...
(Date:1/3/2020)... ... 03, 2020 , ... American actor, Laurence Fishburne, is well-known for his performances ... most know him for the movies he takes part in, he is also the ... explores a vast range of topics to educate its viewers about many issues taking ...
(Date:12/31/2019)... ... December 31, 2019 , ... ... to its Scientific Advisory Board. NanoFUSE Biologics offers a biologically enhanced synthetic therapeutic, ... medical device. , President of NanoFUSE Biologics, Jake Lubinski, said, “We’re fortunate to ...
Breaking Medicine Technology:
(Date:1/10/2020)... ... 2020 , ... Sigma Theta Tau International Honor Society of Nursing (Sigma) was ... awards are regarded as one of the most important and prestigious designations of excellence ... Year competition has recognized Sigma for the last 11 consecutive years. , The following ...
(Date:1/10/2020)... , ... January 10, 2020 , ... ... has announced that it will be attending the HIMSS (Healthcare Information and Management ... , HIMSS is the can’t-miss health information and technology event of the year, ...
(Date:1/8/2020)... ... 08, 2020 , ... Mirror Mirror Beauty Boutique ... of Memorial Readers’ Choice Awards. Located adjacent to Vitenas Cosmetic Surgery, the ... Memorial reflects Mirror Mirror Beauty Boutique’s commitment to the hottest noninvasive trends that ...
(Date:1/7/2020)... ... January 07, 2020 , ... ... and services, today identified six trends that will significantly impact the point of ... “Arguably, the time shared between a provider and patient is the most important ...
(Date:1/7/2020)... Pa. (PRWEB) , ... January 07, 2020 , ... Iconic ... musical talent and being one of the most successful female artists of all time, ... started her first Las Vegas residency and shared in interviews her secrets to making ...
Breaking Medicine News(10 mins):